Cargando…
Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
OBJECTIVE: Flurbiprofen 8.75 mg lozenge and spray are used for symptomatic relief of sore throat, with a rapid onset of analgesia suggesting a localized mechanism of action. Building on previous studies, this investigation aimed to use microautoradiography to visualize the depth penetration of radio...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826073/ https://www.ncbi.nlm.nih.gov/pubmed/33500668 http://dx.doi.org/10.2147/CPAA.S284433 |
_version_ | 1783640455270891520 |
---|---|
author | Turner, Rob Wevrett, Sean Robert Edmunds, Suzanne Brown, Marc Kulasekaran, Anuradha Adegoke, Oluwajoba Farrah, John |
author_facet | Turner, Rob Wevrett, Sean Robert Edmunds, Suzanne Brown, Marc Kulasekaran, Anuradha Adegoke, Oluwajoba Farrah, John |
author_sort | Turner, Rob |
collection | PubMed |
description | OBJECTIVE: Flurbiprofen 8.75 mg lozenge and spray are used for symptomatic relief of sore throat, with a rapid onset of analgesia suggesting a localized mechanism of action. Building on previous studies, this investigation aimed to use microautoradiography to visualize the depth penetration of radiolabeled flurbiprofen into human pharynx tissue using an ex vivo model. Quantification of flurbiprofen in the tissue was performed to provide a quantitative representation of flurbiprofen distribution through the tissue. METHODS: Cadaveric human pharynx tissue was mounted between the donor and receiver compartments of a Franz diffusion cell. After that 8.75 mg spray and dissolved lozenge formulations, containing radiolabeled flurbiprofen, were added to the donor compartment of a Franz diffusion cell. After incubation for one hour, the pharynx tissue was removed, processed, and sectioned both horizontally and vertically. The sections were placed within an imaging cassette to determine the penetration of radiolabeled flurbiprofen visually, before being solubilized to quantify the amount of flurbiprofen present in each section. RESULTS: In the horizontally sectioned samples, flurbiprofen was present in the top layers of all replicates and decreased in intensity throughout the tissue. Of the applied dose, 48.0–99.9% of flurbiprofen was detected in the top one-third of the pharynx tissue, closest to the dosing site, and 0–14.8% of flurbiprofen was detected within the deepest third of pharynx tissue, furthest from the dosing site. In the vertically sectioned tissue samples, radiolabeled flurbiprofen was found at a high intensity at the dosing site and reduced in intensity throughout the thickness of the tissue. Lateral penetration of flurbiprofen was also seen in tissue dosed with the spray. CONCLUSION: Our findings demonstrate that lozenge and spray formulations of flurbiprofen can penetrate throughout the layers of cadaveric human pharynx tissue in an ex vivo model, as visualized by microautoradiography. |
format | Online Article Text |
id | pubmed-7826073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78260732021-01-25 Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method Turner, Rob Wevrett, Sean Robert Edmunds, Suzanne Brown, Marc Kulasekaran, Anuradha Adegoke, Oluwajoba Farrah, John Clin Pharmacol Original Research OBJECTIVE: Flurbiprofen 8.75 mg lozenge and spray are used for symptomatic relief of sore throat, with a rapid onset of analgesia suggesting a localized mechanism of action. Building on previous studies, this investigation aimed to use microautoradiography to visualize the depth penetration of radiolabeled flurbiprofen into human pharynx tissue using an ex vivo model. Quantification of flurbiprofen in the tissue was performed to provide a quantitative representation of flurbiprofen distribution through the tissue. METHODS: Cadaveric human pharynx tissue was mounted between the donor and receiver compartments of a Franz diffusion cell. After that 8.75 mg spray and dissolved lozenge formulations, containing radiolabeled flurbiprofen, were added to the donor compartment of a Franz diffusion cell. After incubation for one hour, the pharynx tissue was removed, processed, and sectioned both horizontally and vertically. The sections were placed within an imaging cassette to determine the penetration of radiolabeled flurbiprofen visually, before being solubilized to quantify the amount of flurbiprofen present in each section. RESULTS: In the horizontally sectioned samples, flurbiprofen was present in the top layers of all replicates and decreased in intensity throughout the tissue. Of the applied dose, 48.0–99.9% of flurbiprofen was detected in the top one-third of the pharynx tissue, closest to the dosing site, and 0–14.8% of flurbiprofen was detected within the deepest third of pharynx tissue, furthest from the dosing site. In the vertically sectioned tissue samples, radiolabeled flurbiprofen was found at a high intensity at the dosing site and reduced in intensity throughout the thickness of the tissue. Lateral penetration of flurbiprofen was also seen in tissue dosed with the spray. CONCLUSION: Our findings demonstrate that lozenge and spray formulations of flurbiprofen can penetrate throughout the layers of cadaveric human pharynx tissue in an ex vivo model, as visualized by microautoradiography. Dove 2021-01-19 /pmc/articles/PMC7826073/ /pubmed/33500668 http://dx.doi.org/10.2147/CPAA.S284433 Text en © 2021 Turner et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Turner, Rob Wevrett, Sean Robert Edmunds, Suzanne Brown, Marc Kulasekaran, Anuradha Adegoke, Oluwajoba Farrah, John Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method |
title | Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method |
title_full | Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method |
title_fullStr | Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method |
title_full_unstemmed | Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method |
title_short | Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method |
title_sort | penetration of flurbiprofen from a locally applied sore throat lozenge and spray into cadaveric human pharynx tissue: a novel ex vivo model and microautoradiography method |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826073/ https://www.ncbi.nlm.nih.gov/pubmed/33500668 http://dx.doi.org/10.2147/CPAA.S284433 |
work_keys_str_mv | AT turnerrob penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod AT wevrettseanrobert penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod AT edmundssuzanne penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod AT brownmarc penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod AT kulasekarananuradha penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod AT adegokeoluwajoba penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod AT farrahjohn penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod |